Adda Grimberg, MD is a Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, and the Scientific Director of the Diagnostic and Research Growth Center at the Children’s Hospital of Philadelphia. Trained as a translational physician scientist, Dr. Grimberg’s research focuses on the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis and clinical issues related to child growth.
One of her principal research areas involves describing, understanding, and addressing disparities in the evaluation and management of growth faltering. She is interested in GH as an illustrative pipeline issue–how the advent of an expensive therapeutic transformed a fundamental aspect of pediatric health care from its medical focus into socially driven health care consumerism.
Dr. Grimberg’s research has been recognized with numerous awards, including the Pediatric Endocrine Society Genentech Clinical Scholar Award and the 2023 Robert M. Blizzard, MD Lectureship, and with coverage in multiple media venues in the United States and abroad, including the New York Times. Dr. Grimberg chaired the taskforce that drafted the Pediatric Endocrine Society guidelines for pediatric GH and IGF-I treatment, served on the Federal Advisory Committee for the National Institute of Child Health and Human Development (NICHD) National Children’s Study, and served on the taskforce that drafted the Endocrine Society scientific statement on endocrine health and health care disparities. She was elected to the Council of the Growth Hormone Research Society.
Dr. Grimberg received her undergraduate and medical education at Cornell University, and completed both her residency in Pediatrics and fellowship in Pediatric Endocrinology at the Children’s Hospital of Philadelphia.